title: Inhibitory effects of histamine H4 receptor antagonists on experimental colitis in the rat.
abstract: The histamine H(4) receptor is a G-protein coupled receptor with little homology to the pro-inflammatory histamine H(1) receptor, expressed on cells of the immune system with hematopoietic lineage such as eosinophils and mast cells. The effects of the recently described highly selective histamine H(4) receptor antagonists JNJ 10191584 and JNJ 7777120 have now been investigated on the acute colitis provoked by trinitrobenzene sulphonic acid over 3 days in the rat. Treatment with JNJ 10191584 (10-100 mg/kg p.o., b.i.d.) caused a dose-dependent reduction in macroscopic damage, inhibition of the TNBS-provoked elevation of both colonic myeloperoxidase and tumour necrosis factor-alpha (TNF-alpha), and a reduction in the histologically assessed increase in mucosal and submucosal thickness and neutrophil infiltration. JNJ 7777120 (100 mg/kg p.o., b.i.d.) likewise reduced the macroscopic injury and the increases in colonic myeloperoxidase and TNF-alpha levels. These findings indicate a pro-inflammatory role for the histamine H(4) receptor in this model and suggest a novel pharmacological approach to the treatment of colitis.
authors.affiliation: Department of Comparative Physiology, Szeged University, Hungary.
authors.forename: Csaba
authors.initials: C
authors.lastname: Varga
authors.forename: Krisztina
authors.initials: K
authors.lastname: Horvath
authors.forename: Aniko
authors.initials: A
authors.lastname: Berko
authors.forename: Robin L
authors.initials: RL
authors.lastname: Thurmond
authors.forename: Paul J
authors.initials: PJ
authors.lastname: Dunford
authors.forename: Brendan J R
authors.initials: BJ
authors.lastname: Whittle
mesh_terms: D000208:Acute Disease; D000818:Animals; D001562:Benzimidazoles / Q000494:pharmacology*; D001835:Body Weight / Q000187:drug effects; D003092:Colitis / Q000139:chemically induced / Q000378:metabolism / Q000517:prevention & control*; D003106:Colon / Q000187:drug effects / Q000378:metabolism / Q000473:pathology; D004305:Dose-Response Relationship, Drug; D007211:Indoles / Q000494:pharmacology*; D008297:Male; D009929:Organ Size / Q000187:drug effects; D009195:Peroxidase / Q000378:metabolism; D010879:Piperazines / Q000494:pharmacology*; D051381:Rats; D017208:Rats, Wistar; D043562:Receptors, G-Protein-Coupled / Q000037:antagonists & inhibitors*; D011968:Receptors, Histamine; D000074040:Receptors, Histamine H4; D014302:Trinitrobenzenesulfonic Acid; D014409:Tumor Necrosis Factor-alpha / Q000378:metabolism
chemical_list: D001562:Benzimidazoles; C418607:HRH4 protein, human; D007211:Indoles; C506811:JNJ 10191584; D010879:Piperazines; D043562:Receptors, G-Protein-Coupled; D011968:Receptors, Histamine; D000074040:Receptors, Histamine H4; D014409:Tumor Necrosis Factor-alpha; C484309:1-((5-chloro-1H-indol-2-yl)carbonyl)-4-methylpiperazine; D014302:Trinitrobenzenesulfonic Acid; D009195:Peroxidase